C4 Therapeutics Inc Stock Ownership - Who owns C4 Therapeutics?

Insider buying vs selling

Have C4 Therapeutics Inc insiders been buying or selling?
Scott N. BoyleChief Business Officer2023-08-30661$2.93
Jolie SiegelChief Legal Officer2023-08-30661$2.93
Stewart FisherChief Scientific Officer2023-08-30661$2.93
Kelly SchickChief People Officer2023-08-30661$2.93
Andrew HirschPresident CEO2023-08-302,205$2.93
Lauren WhiteChief Financial Officer2023-08-30661$2.93
Glenn DubinDirector2023-07-033,887$2.83
Donna Roy GroganDirector2023-07-034,858$2.83
Kenneth Carl AndersonDirector2023-07-033,976$2.83
Donna Roy GroganDirector2023-04-034,298$3.20

1 of 3

CCCC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CCCC insiders and whales buy or sell their stock.

CCCC Shareholders

What type of owners hold C4 Therapeutics Inc stock?
Marc A. Cohen16.89%8,308,874$15.87MInsider
Wasatch Advisors LP14.64%7,199,491$13.75MInstitution
Alain J. Cohen12.39%6,094,001$11.64MInsider
Price T Rowe Associates Inc5.75%2,828,605$5.40MInstitution
Soleus Capital Management LP5.47%2,692,020$5.14MInstitution
Millennium Management LLC4.34%2,135,597$4.08MInstitution
Blackrock Inc4.24%2,086,563$3.99MInstitution
Vanguard Group Inc3.86%1,900,356$3.63MInstitution
Bain Capital Life Sciences Investors LLC3.34%1,642,210$3.14MInstitution
Tcg Crossover Management LLC2.60%1,276,574$2.44MInstitution

1 of 3

CCCC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CCCC66.72%33.28%Net BuyingNet Buying
IOBT18.59%78.16%Net BuyingNet Buying
SPRB58.74%41.26%Net BuyingNet Buying
RLMD53.48%2.87%Net Buying
ACHV16.93%44.76%Net Selling

C4 Therapeutics Stock Ownership FAQ

Who owns C4 Therapeutics?

C4 Therapeutics (NASDAQ: CCCC) is owned by 69.38% institutional shareholders, 34.61% C4 Therapeutics insiders, and 0.00% retail investors. Marc A. Cohen is the largest individual C4 Therapeutics shareholder, owning 8.31M shares representing 16.89% of the company. Marc A. Cohen's C4 Therapeutics shares are currently valued at $15.87M.

If you're new to stock investing, here's how to buy C4 Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.